CytomX Therapeutics CTMX Faces Modest Decline as Support Levels Hold China Intensifies Regulatory Scrutiny on Food Delivery Ghost Kitchens ARTL Q4 2025 Earnings Narrowed Loss Beats Estimates But Stock Dips on Lack of Revenue More Buyers Return to Housing Market NAR Report Indicates BBLG Q1 2026 Earnings SmallerthanExpected Loss on No Revenue as Bone Graft Developer Continues RD Progress DTST Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise LMNR Q1 2026 Earnings EPS Misses Estimates Stock Declines FIZZ Q1 2026 Earnings EPS Misses Estimates Amid Mixed Consumer Trends KALU Q1 2026 Earnings EPS Surges 97 Above Estimates Stock Falls Amid Market Concerns MDGL Q1 2026 Earnings Narrowerthanexpected loss highlights progress in Rezdiffra launch FRPT Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Negative Stock Reaction